3-(Dimethylamino)propane-1,2-diyl distearate

Catalog No. :
ACUTEQ731
CAS No. :
121315-93-3
Molecular Formula :
C41H81NO4
Molecular Weight :
652.10

IUPAC Name:3-(dimethylamino)propane-1,2-diyl distearate

3-(Dimethylamino)propane-1,2-diyl distearate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg99%$70.00Login to see priceIn stockInquiry
100mg99%$119.00Login to see priceIn stockInquiry
250mg99%$224.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Dimethylamino)propane-1,2-diyl distearate
IUPAC Name3-(dimethylamino)propane-1,2-diyl distearate
Molecular FormulaC41H81NO4
Molecular Weight652.10
SMILESO=C(CCCCCCCCCCCCCCCCC)OCC(CN(C)C)OC(CCCCCCCCCCCCCCCCC)=O
InChI KeyRVBUSVJSKGVQQS-UHFFFAOYSA-N
Synonym18:0 DAP;1,2-DISTEAROYL-3-DIMETHYLAMMONIUM-PROPANE;Octadecanoic acid, 1-[(dimethylamino)methyl]-1,2-ethanediyl ester;N,N,2-trimethyl-2-((octadecyloxy)methyl)henicosan-1-amine;3-(Dimethylamino)propane-1,2-diyl distearate
CAS No.121315-93-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACUTEQ731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUTEQ731 route product structure diagram
    ACUTEQ731121315-93-3 In Stock
Inquiry

2. ACUTEQ731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJWAN185 route compound structure diagram
    ACJWAN1854485-12-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUTEQ731 route product structure diagram
    ACUTEQ731121315-93-3 In Stock
Inquiry

Comments (0)